Search research articles
Contact Us
Filters
Showing results (91-100 of 102) with videos related to
Page
of 11
Sort By:
Bone Marrow Transplantation
|
May 1, 2012
The EBMT activity survey: 1990-2010
J R Passweg, H Baldomero, A Gratwohl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 17, 2017
Salvage high-dose chemotherapy in female patients with relapsed/refractory germ-cell tumors: a retrospective analysis of the European Group for Blood and Marrow Transplantation (EBMT)
U De Giorgi, S Richard, M Badoglio, et al.
Leukemia
|
June 29, 2007
Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome
P Corradini, A Dodero, L Farina, et al.
Bone Marrow Transplantation
|
April 16, 2013
Hematopoietic SCT in Europe: data and trends in 2011
J R Passweg, H Baldomero, M Bregni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 26, 2005
Secondary acute myeloid leukaemia: results of conventional treatments. Experience of GIMEMA trials
L Pagano, A Pulsoni, M Vignetti, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 13, 2019
Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodine-refractory differentiated thyroid cancer patients in Italy
L D Locati, A Piovesan, C Durante, et al.
Bone Marrow Transplantation
|
December 18, 2007
Allogeneic hematopoietic cell transplantation for metastatic breast cancer
N T Ueno, J D Rizzo, T Demirer, et al.
Leukemia
|
June 8, 2007
Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi)
C Tarella, M Zanni, M Di Nicola, et al.
British Journal of Cancer
|
October 24, 2013
Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessment
U Thiel, E Koscielniak, F Blaeschke, et al.
Klinische Padiatrie
|
July 24, 2012
Human leukocyte antigen distribution in German Caucasians with advanced Ewing's sarcoma
U Thiel, P Wolf, A Wawer, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 102) with videos related to
Sort By:
Page
of 11
Bone Marrow Transplantation
|
May 1, 2012
The EBMT activity survey: 1990-2010
J R Passweg, H Baldomero, A Gratwohl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 17, 2017
Salvage high-dose chemotherapy in female patients with relapsed/refractory germ-cell tumors: a retrospective analysis of the European Group for Blood and Marrow Transplantation (EBMT)
U De Giorgi, S Richard, M Badoglio, et al.
Leukemia
|
June 29, 2007
Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome
P Corradini, A Dodero, L Farina, et al.
Bone Marrow Transplantation
|
April 16, 2013
Hematopoietic SCT in Europe: data and trends in 2011
J R Passweg, H Baldomero, M Bregni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 26, 2005
Secondary acute myeloid leukaemia: results of conventional treatments. Experience of GIMEMA trials
L Pagano, A Pulsoni, M Vignetti, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 13, 2019
Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodine-refractory differentiated thyroid cancer patients in Italy
L D Locati, A Piovesan, C Durante, et al.
Bone Marrow Transplantation
|
December 18, 2007
Allogeneic hematopoietic cell transplantation for metastatic breast cancer
N T Ueno, J D Rizzo, T Demirer, et al.
Leukemia
|
June 8, 2007
Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi)
C Tarella, M Zanni, M Di Nicola, et al.
British Journal of Cancer
|
October 24, 2013
Allogeneic stem cell transplantation for patients with advanced rhabdomyosarcoma: a retrospective assessment
U Thiel, E Koscielniak, F Blaeschke, et al.
Klinische Padiatrie
|
July 24, 2012
Human leukocyte antigen distribution in German Caucasians with advanced Ewing's sarcoma
U Thiel, P Wolf, A Wawer, et al.
Page
of 11